Bicycle Therapeutics (NASDAQ:BCYC) reported quarterly losses of $(0.96) per share. This is a 62.71 percent decrease over losses of $(0.59) per share from the same period last year.
Related Posts
Superior Group Of Companies Announces Board Observer Program, Designed To Expose Traditionally Underrepresented Groups To Public Company Corporate Governance
– Designed to Expose Traditionally Underrepresented Groups to Public Company Corporate Governance –– Kelly Richmond Pope Named First Participant –ST. PETERSBURG, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Superior Group of
B of A Securities Downgrades F5 to Neutral
B of A Securities analyst Tal Liani downgrades F5 (NASDAQ:FFIV) from Buy to Neutral.
EU Demands Fair Pay For Artists On Music Streaming Platforms
The European Parliament has called for fair and sustainable rules in the music streaming industry.
In a resolution passed with strong support (532 votes to 61, with 33 abstentions), the Parliament urges the creation of EU regulations to tackle current imbalances in the sector.